Metabolomics Identifies Biomarker Signatures to Differentiate Pancreatic Cancer from Type 2 Diabetes Mellitus in Early Diagnosis.

Hongmin Xu,Lei Zhang,Hua Kang, Jie Liu,Jiandong Zhang, Jie Zhao,Shuye Liu

International journal of endocrinology（2021）

引用 4|浏览3

暂无评分

摘要

We succeeded in screening differential metabolite ions among PC and DM patients and healthy individuals, thus providing a preliminary basis for screening the biomarkers for the early diagnosis of PC.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要